NCT06765668: An ongoing trial by Impax Laboratories, LLC
This trial is ongoing. It must report results 11 months, 4 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06765668 |
|---|---|
| Title | Open-Label Phase 4 Study of CREXONT® (Carbidopa and Levodopa) Extended Release Capsules in Parkinson's Disease Patients |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 12, 2025 |
| Completion date | Nov. 30, 2025 |
| Required reporting date | Nov. 30, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |